^
+ Follow JOHN DINEEN Tag
Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 741278
                    [Title] => GE leads $100-M fund  for breast cancer challenge
                    [Summary] => 

GE and four venture capital firms have pledged $100 million for a six-month contest to finance ideas for improving breast cancer detection.

[DatePublished] => 2011-10-27 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) [1] => Array ( [ArticleID] => 728197 [Title] => GE Healthcare to invest $1 billion in new oncology solutions [Summary] =>

GE Healthcare, the health business of General Electric, announced its plans to dedicate $1 billion of its total R&D budget over the next five years to expand its advanced cancer diagnostic and molecular imaging capabilities, as well as its world-class technologies for the manufacture of biopharmaceuticals and for cancer research.

[DatePublished] => 2011-09-19 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Lifestyle Business [SectionUrl] => business-life [URL] => ) ) )
JOHN DINEEN
Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 741278
                    [Title] => GE leads $100-M fund  for breast cancer challenge
                    [Summary] => 

GE and four venture capital firms have pledged $100 million for a six-month contest to finance ideas for improving breast cancer detection.

[DatePublished] => 2011-10-27 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) [1] => Array ( [ArticleID] => 728197 [Title] => GE Healthcare to invest $1 billion in new oncology solutions [Summary] =>

GE Healthcare, the health business of General Electric, announced its plans to dedicate $1 billion of its total R&D budget over the next five years to expand its advanced cancer diagnostic and molecular imaging capabilities, as well as its world-class technologies for the manufacture of biopharmaceuticals and for cancer research.

[DatePublished] => 2011-09-19 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Lifestyle Business [SectionUrl] => business-life [URL] => ) ) )
abtest
Are you sure you want to log out?
X
Login

Philstar.com is one of the most vibrant, opinionated, discerning communities of readers on cyberspace. With your meaningful insights, help shape the stories that can shape the country. Sign up now!

Get Updated:

Signup for the News Round now

FORGOT PASSWORD?
SIGN IN
or sign in with